CAS No. |
952654-62-5 |
中文名称 |
(2S,3S,4S,5R,6S)-6-((4-((4-氟苄基)氨基甲酰基)-1-甲基-2-(2-(5-甲基-1,3,4-噁二唑-2-甲酰氨基)丙-2-基)-6-氧代-1,6-二氢嘧啶-5-基)氧基)-3,4,5-三羟基四氢-2H-吡喃-2-羧酸 |
英文名称 |
(2S,3S,4S,5R,6S)-6-((4-((4-Fluorobenzyl)carbamoyl)-1-methyl-2-(2-(5-methyl-1,3,4-oxadiazole-2-carboxamido)propan-2-yl)-6-oxo-1,6-dihydropyrimidin-5-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid |
别名 |
Raltegravir b-D-glucuronide;4-[[[(4-Fluorophenyl)Methyl]aMino]carbonyl]-1,6-dihydro-1-Methyl-2-[1-Methyl-1-[[(5-Methyl-1,3,4-oxadiazol-2-yl)carbonyl]aMino]ethyl]-6-oxopyriMidin-5-yl;Reaxys ID: 21791844;4-[[[(4-Fluorophenyl)methyl]amino]carbonyl]-1,6-dihydro-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxopyrimidin-5-yl -D-Glucopyranosiduronic Acid;Raltegravir -D-Glucuronide;Raltegravir-beta-D-glucuronide;β-D-Glucopyranosiduronic acid, 4-[[[(4-fluorophenyl)methyl]amino]carbonyl]-1,6-dihydro-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxopyrimidin-5-yl;Raltegravir Impurity 9(Raltegravir β-D-Glucuronide) |
标准英文名 |
(2S,3S,4S,5R,6S)-6-((4-((4-fluorobenzyl)carbamoyl)-1-methyl-2-(2-(5-methyl-1,3,4-oxadiazole-2-carboxamido)propan-2-yl)-6-oxo-1,6-dihydropyrimidin-5-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid |
分子式 |
C26H29FN6O11 |
分子量 |
620.55
|
精确分子量 |
620.19
|
SMILES |
O(C1=C(C(NCC2=CC=C(F)C=C2)=O)N=C(C(NC(=O)C3=NN=C(C)O3)(C)C)N(C)C1=O)[C@@H]4O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]4O |
标准SMILES |
CC1=NN=C(O1)C(=O)NC(C)(C)C1=NC(=C(O[C@@H]2O[C@@H]([C@@H](O)[C@H](O)[C@H]2O)C(O)=O)C(=O)N1C)C(=O)NCC1C=CC(F)=CC=1 |
性状 |
No data available |
用途 |
For laboratory research purposes. Not for drug or household use. |
信号词 |
Warning |
InChIKey |
DNIJULFVNPGGMF-LKUMGPRMSA-N |
危险类别(旧) |
H302,H315,H319,H335 |
存储要求 |
No data available,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage. |